Kenvue Inc. (NYSE:KVUE) Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio cut its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 4.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 673,594 shares of the company's stock after selling 29,566 shares during the period. Public Employees Retirement System of Ohio's holdings in Kenvue were worth $14,381,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of KVUE. Price T Rowe Associates Inc. MD raised its position in shares of Kenvue by 3.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 245,885,918 shares of the company's stock worth $5,249,665,000 after acquiring an additional 8,211,748 shares during the period. Vanguard Group Inc. raised its holdings in Kenvue by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 218,543,705 shares of the company's stock worth $4,665,908,000 after purchasing an additional 1,636,741 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in Kenvue by 12.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 97,661,344 shares of the company's stock worth $2,085,070,000 after purchasing an additional 10,682,003 shares during the period. Geode Capital Management LLC raised its stake in shares of Kenvue by 3.1% during the 4th quarter. Geode Capital Management LLC now owns 46,068,931 shares of the company's stock worth $980,989,000 after buying an additional 1,391,854 shares during the period. Finally, Franklin Resources Inc. raised its stake in shares of Kenvue by 61.5% during the 4th quarter. Franklin Resources Inc. now owns 42,719,377 shares of the company's stock worth $912,059,000 after buying an additional 16,269,721 shares during the period. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on KVUE shares. Redburn Atlantic started coverage on Kenvue in a report on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price target for the company. Evercore ISI began coverage on shares of Kenvue in a research report on Monday, March 24th. They set an "in-line" rating and a $25.00 price target for the company. Piper Sandler lifted their price objective on Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a research note on Monday, February 24th. Barclays boosted their price target on shares of Kenvue from $22.00 to $23.00 and gave the stock an "equal weight" rating in a research note on Monday, May 12th. Finally, Canaccord Genuity Group boosted their price objective on Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a research report on Wednesday, March 5th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Kenvue has a consensus rating of "Hold" and an average price target of $25.33.

Kenvue Stock Performance

Shares of NYSE KVUE traded down $0.38 during midday trading on Wednesday, hitting $23.55. 10,980,527 shares of the company's stock were exchanged, compared to its average volume of 16,329,764. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The stock's 50 day moving average price is $23.25 and its 200-day moving average price is $22.63. The firm has a market cap of $45.19 billion, a P/E ratio of 44.43, a PEG ratio of 2.62 and a beta of 1.02. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. The company had revenue of $3.74 billion during the quarter, compared to analyst estimates of $3.69 billion. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. The firm's quarterly revenue was down 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.28 EPS. Equities research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th will be issued a $0.205 dividend. This represents a $0.82 annualized dividend and a yield of 3.48%. The ex-dividend date is Wednesday, May 14th. Kenvue's payout ratio is currently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.